Risk of immune hemolytic anemia in children following immunization

Vaccine

Volumn 27, Issue 52, 2009, Pages 7394-7397

  Naleway, Allison L ^a   Belongia, Edward A ^b   Donahue, James G ^b   Kieke, Burney A ^b   Glanz, Jason M ^c  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b MARSHFIELD CLINIC   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

Hemolysis; Hemolytic anemia; Pediatrics; Vaccine safety

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; POLIOMYELITIS VACCINE;

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CHILD; COHORT ANALYSIS; DRUG EFFECT; DRUG EXPOSURE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VACCINATION;

ADOLESCENT; ANEMIA, HEMOLYTIC; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HEPATITIS B VACCINES; HUMANS; INCIDENCE; INFANT; MALE; RISK; UNITED STATES; VACCINATION;

EID: 70849100236     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.023     Document Type: Article

References (20)

1. Howson CP, Howe CJ, Fineberg HV, editors, and the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines, Division of Health Promotion and Disease Prevention, Institute of Medicine, National Academy of Sciences. Adverse effects of pertussis and rubella vaccines. Washington, DC: Institute of Medicine, 1991.
2. Zupanska B., Lawkowicz W., Gorska B., Kozlowska J., Ochocka M., Rokicka-Milewska R., et al. Autoimmune haemolytic anaemia in children. Br J Haematol 34 (1976) 511-520
3. Haneberg B., Winsnes R., Dalen A., Vogt H., and Finne P.H. Acute hemolytic anemia related to diphtheria-pertussis-tetanus vaccination. Acta Paediatr Scand 67 (1978) 345-350
4. Coulter H.L., and Loe Fisher B. A shot in the dark: Why the P in the DPT vaccination may be hazardous to your child's health (1991), Avery Publishing Group, Garden City Park
5. Olcay L., Duzova A., and Gumruk F. A warm antibody mediated acute hemolytic anemia with reticulocytopenia in a four-month-old girl requiring immunosuppressive therapy. Turk J Pediatr 41 (1999) 239-244
6. Seltsam A., Shukry-Schulz S., and Salama A. Vaccination-associated immune hemolytic anemia in two children. Transfusion 40 (2000) 907-909
7. Chen R.T., Glasser R.W., Rhodes P.H., Davis R.L., Barlow W.E., Thompson R.S., et al. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. Pediatrics 99 (1997) 765-773
8. Chen R.T., DeStefano F., Davis R.L., Jackson L.A., Thompson R.S., Mullooly J.P., et al. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. Bull World Health Organ 78 (2000) 186-194
9. DeStefano F. The Vaccine Safety Datalink Project. Pharmacoepidemiol Drug Saf 10 (2001) 403-406
10. Farrington C.P. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 51 (1995) 228-235
11. Farrington C.P., Nash J., and Miller E. Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol 143 (1996) 1165-1173
12. Smith A.H., and Bates M.N. Confidence limit analyses should replace power calculations in the interpretation of epidemiologic studies. Epidemiology 3 (1992) 449-452
13. Mullooly J.P., Crane B., and Chun C. Trivalent inactivated influenza vaccine safety in children: assessing the contribution of telephone encounters. Vaccine 24 (2000) 2256-2263
14. Glanz J.M., McClure D.L., Xu S., Hambidge S.J., Lee M., Kolczak M.S., et al. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol 59 (2006) 808-818
15. France E.K., Glanz J.M., Xu S., Hambidge S., Yamasaki K., Black S.B., et al. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics 121 (2008) e687-e692
16. McClure D.L., Glanz J.M., Xu S., Hambidge S.J., Mullooly J.P., and Baggs J. Comparison of epidemiologic methods for active surveillance of vaccine safety. Vaccine 26 (2008) 3341-3345
17. Gedikoglu A.G., and Cantez T. Haemolytic anaemia relapses after immunization and pertussis. Lancet 2 (1967) 894-895
18. Bossi E., and Wagner H.P. Autoimmune hemolytic anemia and cytomegalovirus infection in a six-month old child treated with azathioprine. Helv Paediatr Acta 27 (1972) 155-162
19. Downes K.A., Domen R.E., McCarron K.F., and Bringelsen K.A. Acute autoimmune hemolytic anemia following DTP vaccination: report of a fatal case and review of the literature. Clin Pediatr 40 (2001) 355-358
20. Johnson S.T., McFarland J.G., Kelly K.J., Casper J.T., and Gottschall J.L. Transfusion support with RBCs from an Mk homozygote in a case of autoimmune hemolytic anemia following diphtheria-pertussis-tetanus vaccination. Transfusion 42 (2002) 567-571